AU2001270580A1 - Benzodiazepines as inhibitors of hpv e1 helicase - Google Patents
Benzodiazepines as inhibitors of hpv e1 helicaseInfo
- Publication number
- AU2001270580A1 AU2001270580A1 AU2001270580A AU7058001A AU2001270580A1 AU 2001270580 A1 AU2001270580 A1 AU 2001270580A1 AU 2001270580 A AU2001270580 A AU 2001270580A AU 7058001 A AU7058001 A AU 7058001A AU 2001270580 A1 AU2001270580 A1 AU 2001270580A1
- Authority
- AU
- Australia
- Prior art keywords
- helicase
- benzodiazepines
- hpv
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0015904 | 2000-06-28 | ||
| GBGB0015904.6A GB0015904D0 (en) | 2000-06-28 | 2000-06-28 | Inhibitors of HPV E1 helicase enzyme |
| PCT/EP2001/006895 WO2002000632A1 (en) | 2000-06-28 | 2001-06-19 | Benzodiazepines as inhibitors of hpv e1 helicase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001270580A1 true AU2001270580A1 (en) | 2002-01-08 |
Family
ID=9894630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001270580A Abandoned AU2001270580A1 (en) | 2000-06-28 | 2001-06-19 | Benzodiazepines as inhibitors of hpv e1 helicase |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6703387B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1299364A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004501904A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2001270580A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2411157A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0015904D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002000632A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1615878B1 (en) | 2003-01-14 | 2012-04-04 | Cytokinetics, Inc. | Compounds, compositions and methods of treatment for heart failure |
| ATE411981T1 (de) * | 2003-06-10 | 2008-11-15 | Smithkline Beecham Corp | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung |
| CA2528336A1 (en) | 2003-06-12 | 2005-01-20 | Smithkline Beecham Corporation | Tetrahydrocarbazole derivatives and their pharmaceutical use |
| KR101276136B1 (ko) | 2004-06-17 | 2013-06-18 | 싸이토키네틱스, 인코포레이티드 | 화합물, 조성물 및 방법 |
| US7176222B2 (en) | 2004-07-27 | 2007-02-13 | Cytokinetics, Inc. | Syntheses of ureas |
| US20060161076A1 (en) * | 2005-01-06 | 2006-07-20 | Diamics, Inc. | Systems and methods for collection of cell clusters |
| US20060189893A1 (en) * | 2005-01-06 | 2006-08-24 | Diamics, Inc. | Systems and methods for detecting abnormal cells |
| US7538223B2 (en) | 2005-08-04 | 2009-05-26 | Cytokinetics, Inc. | Compounds, compositions and methods |
| US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| WO2007070683A2 (en) | 2005-12-15 | 2007-06-21 | Cytokinetics, Inc. | Certain chemical entities, compositions and methods |
| WO2007078815A2 (en) | 2005-12-16 | 2007-07-12 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| JP5178526B2 (ja) | 2005-12-19 | 2013-04-10 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
| GB0619325D0 (en) | 2006-09-30 | 2006-11-08 | Univ Strathclyde | New compounds |
| WO2011046646A2 (en) * | 2009-07-10 | 2011-04-21 | Microbiotix, Inc. | Inhibitors of filovirus entry into host cells |
| CN102902895B (zh) * | 2010-05-18 | 2017-04-05 | 小江生物技术有限公司 | 预防和治疗人乳头瘤病毒感染类疾病的化合物的筛选方法 |
| JP2013010740A (ja) * | 2011-06-03 | 2013-01-17 | Sumitomo Chemical Co Ltd | イソキサゾリン化合物を製造する方法 |
| EP3367798A1 (en) | 2015-10-28 | 2018-09-05 | Syngenta Participations AG | Microbiocidal oxadiazole derivatives |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1455048A (fr) * | 1965-01-09 | 1966-04-01 | Clin Byla Ets | Composés de la série des benzodiazépines et leur préparation |
| TW219896B (cg-RX-API-DMAC7.html) * | 1988-07-07 | 1994-02-01 | Duphar Int Res | |
| US4847129A (en) * | 1988-09-16 | 1989-07-11 | Continental Pet Technologies, Inc. | Multilayer preform for hot fill containers |
| US5141735A (en) * | 1990-06-18 | 1992-08-25 | Hoffman-La Roche, Inc. | Substituted amino-benzodiazepines having anitviral activity |
| BR9913226A (pt) * | 1998-09-01 | 2001-05-22 | Innogenetics Nv | Benzodiazepinas e derivados de benzotiazepinas e peptìdios de hbsag ligados a anexinas, suas composições e uso |
| CA2342858A1 (en) * | 1998-09-04 | 2000-03-16 | Institute Of Molecular & Cell Biology | Method of screening compounds useful in the treatment of a desease caused by or exacerbated by mpv |
-
2000
- 2000-06-28 GB GBGB0015904.6A patent/GB0015904D0/en not_active Ceased
-
2001
- 2001-06-19 WO PCT/EP2001/006895 patent/WO2002000632A1/en not_active Ceased
- 2001-06-19 JP JP2002505380A patent/JP2004501904A/ja active Pending
- 2001-06-19 EP EP01949420A patent/EP1299364A1/en not_active Withdrawn
- 2001-06-19 CA CA002411157A patent/CA2411157A1/en not_active Abandoned
- 2001-06-19 AU AU2001270580A patent/AU2001270580A1/en not_active Abandoned
- 2001-06-26 US US09/892,148 patent/US6703387B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6703387B2 (en) | 2004-03-09 |
| WO2002000632A1 (en) | 2002-01-03 |
| EP1299364A1 (en) | 2003-04-09 |
| GB0015904D0 (en) | 2000-08-23 |
| CA2411157A1 (en) | 2002-01-03 |
| US20020128262A1 (en) | 2002-09-12 |
| JP2004501904A (ja) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001270580A1 (en) | Benzodiazepines as inhibitors of hpv e1 helicase | |
| AU2002238418A1 (en) | Use of DNA repair enzymes as MMP-1 inhibitors | |
| AU2001232036A1 (en) | Pyrimidine derivatives as selective inhibitors of cox-2 | |
| AU2001244399A1 (en) | Gamma-secretase inhibitors | |
| AU2003261434A1 (en) | Iminothiazolidinones as inhibitors of hcv replication | |
| AU2001258771A1 (en) | -secretase inhibitors | |
| AU2001296961A1 (en) | 17-beta-hydroxysteroid dehydrogenase-ii inhibitors | |
| AU2001236720A1 (en) | Compositions useful as inhibitors of erk | |
| AU2001293373A1 (en) | 2-guanidino-4-arylchinazolines as NHE-3 inhibitors | |
| AU2002224808A1 (en) | Use of thienopyrimidines | |
| AU6381701A (en) | Bisamidino compounds as nhe-3 inhibitors | |
| AU2001245764A1 (en) | Novel compounds and compositions as protease inhibitors | |
| AU2001296864A1 (en) | Detection of varicella-zoster virus | |
| AU2001274571A1 (en) | Micro-array of organism-associated substance | |
| AU2002211370A1 (en) | Inhibition of tgf-beta and uses thereof | |
| AU2002304853A1 (en) | Substituted benzopyranones as telomerase inhibitors | |
| AU2002214038A1 (en) | Inhibitors of transglutaminases | |
| AU2001247196A1 (en) | Methods and compositions for detection of disease | |
| AU2001229530A1 (en) | Detection of fermentation-related microorganisms | |
| AU2001244108A1 (en) | Formulations for states of dehydration | |
| AU2001254754A1 (en) | Use of alkoxy esters | |
| AU2002213189A1 (en) | Improvement of endothelial cell-cell cohesion | |
| AU2001251004A1 (en) | Detection of viable agents | |
| AU2001280461A1 (en) | Substituted pyrrole compounds and their use as spla2 inhibitors | |
| AU2002221319A1 (en) | Detection of compounds such as thyroxine |